Detection of CNVs in NGS Data Using VS-CNV

Area of Science:

• Genetics
• Bioinformatics
• Genomic Medicine

Background:

• Copy number variations (CNVs) are significant contributors to various genetic diseases, including cancer, Parkinson's disease, pancreatitis, and lupus.
• Current standard methods for CNV detection, such as microarrays for large CNVs and multiplex ligation-dependent probe amplification (MLPA) for gene-sized CNVs, are specialized and resource-intensive.

Purpose of the Study:

• To provide an overview of bioinformatic approaches for CNV detection using next-generation sequencing (NGS) data.
• To evaluate VS-CNV, a commercial tool for robust CNV calling from NGS data.

Main Methods:

• Review of various bioinformatic strategies for CNV detection from NGS data.
• Application and assessment of the VS-CNV software tool for analyzing gene panel and exome sequencing data.

Main Results:

• NGS-based bioinformatic analysis presents a unified and potentially more efficient approach to CNV detection compared to traditional assays.
• VS-CNV demonstrates robust capabilities for calling copy number variations across different NGS data types, including gene panels and exomes.

Conclusions:

• NGS-based CNV detection methods, including tools like VS-CNV, can reduce costs, resources, and analysis time for clinical laboratories already utilizing NGS.
• Bioinformatic analysis of NGS data is emerging as a powerful alternative to specialized assays for comprehensive CNV detection.